Experiment 1142459
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | TAKASUGI,BJ: JONES,SE: ROBERTONE,AB:. (1984). PHASE II TRIAL OF VINZOLIDINE,AN ORAL VINCA ALKALOID, IN HODGKIN'S DISEASE AND NON-HODGKIN'S LYMPHOMA.. 68(11) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN THIS PHASE II TRIAL, 13 PATIENTS WITH NON-HODGKIN'S AND 8 WITH HODGKIN'S LYMPHOMA WERE TREATED ON DAY 1 EVERY 14-21 DAYS. THERE WERE NO COMPLETE REMISSIONS. THERE WAS ONE PARTIAL REMISSION IN THE NON-HODGKIN'S AND 4 IN THE HODGKIN'S GROUP. MYELOSUPPRESSION WAS DOSE RELATED. THREE PATIENTS WERE HOSPITALIZED WITH GRANULOCYTOPENIA. GASTROINTESTINAL SIDE EFFECTS WERE FREQUENT BUT MILD AND DID NOT REQUIRE TREATMENT. 6 PATIENTS HAD REVERSIBLE LOWER EXTREMETY WEAKNESS. |
| Dose amount | 50.0 MG |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |